Discovering Associations of Adverse Events with Pharmacotherapy in Patients with Non-Small Cell Lung Cancer Using Modified Apriori Algorithm

Table 2

Different chemotherapy regimens used for advanced cancers.

Agents	Number of patients	Percentage of all chemotherapy patients
Platinum-based drugs and pemetrexed	2,582	50.41%
Platinum-based drugs and paclitaxel	1,451	28.33%
Platinum-based drugs and gemcitabine	807	15.76%
Platinum-based drugs and docetaxel	574	11.21%
Platinum-based drugs and etoposide	189	3.69%
Platinum-based drugs and vinorelbine	33	0.64%